Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-AlF-FAPi-04 PET/CT in Solid Tumors
NCT06126705Phase 1Unknown
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]AlF-NOTA-FAPI-04 in solid tumor (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Sensitivity of 18F-AlF-FAPi-04 at 6 months and Specificity of 18F-AlF-FAPi-04 at 6 months. Status: unknown.
02
Drugs
[18F]AlF-NOTA-FAPI-04
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06126705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06126705.